We have got 300+ patent applications worldwide and 200+ patents authorized. Our products have been CE marked and sold to more than 80 countries. Culture featured in “Care, Creativity, Cooperation”.
MEDPRIN is short for “Medical Printing”. We specialize in research, development, and manufacturing of high-end medical devices, with a focus on tissue regenerative implantable medical devices.
To become one of the global leaders in implantable medical device and to serve patients and physicians worldwide with outstanding products and impressive services.
Step by step, Medprin gradually expands its coverage across the world, and competes with leading medical device companies.
Countries and Regions
Medprin has established our own interdisciplinary innovation team covering the whole industrial chain of high performance medical device development.
Medprin has a market-driven product development strategy and works with KOLs for product development.
To be continued
Immiseal，Retissue and more new products
1 Newly-constructed headquarters, MEDPRIN edifice is fully operational
1 Immiseal，Retissue and more new products
1 StypCel™ - CE Certificate
1 LivPrint™- CE Certificate
2 Additive manufacturing facilities - National Patent Sliver Award
3 ReDura™ - National Patent Excellent Award
1 Certificate of Intellectual Property Management System
2 Member of National Additive Manufacturing Association
1 National Biological 3D Printing and Implantable Medical Device Research Center
2 ReDura™ - Nomination For National Industry Awards Recranio ™ CFDA
3 Top 7th Globally Rank of 3D Bio-Printing Patent Number
1 NeoDura ™ CE
1 ReDura ™ CFDA
1 National Enterprise Postdoctoral Program
1 National High-Tech Enterprise
1 ReDura ™ CE, ISO 13485
1 Over 4,000 square meters GMP facility and animal study facility are established